SEC Form 4 · accession 0001209191-18-002268
Odonate Therapeutics, Inc. · ODT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph P O'Connell
Officer — Chief Medical Officer
Period of report
Jan 2, 2018
Accepted (ET)
Jan 4, 2018 · 8:51 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001717452
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $24.73 | Jan 2, 2018 | A | 11,265 | A | — | Jan 2, 2028 | Common Stock | 11,265 | 11,265 | D |
Explanation of responses
- F1The stock options vest with respect to 25% of the underlying shares on 01/02/2019, with the remaining shares vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer through each vesting date.